FDA ends Teva Plan B OTC dominance
Plan B is now going generic. NPR reports that the FDA did a 180 on its July 2012 marketing decision that allowed the emergency contraception to be sold over the counter without an age restriction.
The age-free availability came after legal wrangling that brought together the FDA, the Department of Justice, and the United States District Court for the Eastern District of New York.
Pro-limit parties, which included the Department of Justice and the White House, backed off, keeping it out of the Supreme Court. The détente came with a provision in which the FDA granted drugmaker Teva three years of generic protection. NPR reports that the regulator has changed its mind as long as generic labels note that the drug is meant for women 17 or older.